$34K USD Wholesale Acquisition Cost per patient per year. The next HUGE hurdle for Sanofi is the payer negotiations. They will be lucky to get 1/2 of that.
If dupilumab is headed for a UNIS WI I would suspect a funding announcement on the heels of the FDA approval. This does all match with the UNIS timeline ...![]()
$34K USD Wholesale Acquisition Cost per patient per year. The...
Add to My Watchlist
What is My Watchlist?